+37.4%
CVS vs UMAC
+488.3%
-450.8%
-43.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | UMAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -3.2% | +3.2% | -0.1% |
| 7D | -2.0% | -4.0% | +2.0% | -1.9% |
| 30D | +1.9% | -9.4% | +11.3% | +2.0% |
| 3M | -2.2% | +3.0% | -5.2% | -2.4% |
| 6M | +26.7% | +27.2% | -0.5% | +25.7% |
| YTD | +22.9% | +84.7% | -61.8% | +21.1% |
| 1Y | +32.9% | +136.5% | -103.6% | +30.1% |
| All | +37.4% | +488.3% | -450.8% | +29.7% |
Cumulative growth
Daily Returns
Daily percentage return beside UMAC.
Daily Out/Under-Performance
Portfolio return minus UMAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UMAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded UMAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling